Altered Messenger RNA and Unique Mutational Profiles of p53 and Rb in Human Esophageal Carcinomas

Cancer Research

Volumn 53, Issue 8, 1993, Pages 1889-1894

  Chang, Esther H ^e,f   Srivastava, Shiv ^e,f   Zou, Zhi Qiang ^e,f   Boynton, Robert F ^b   Meltzer, Stephen J ^a,b,c,d   McDaniel, Tim ^b,c  

^a Department of Microbiology and Immunology ^*  (United States)

^b Medicine ^*  (United States)

^c Molecular and Cell Biology Graduate Program   (United States)

^d Center for Cancer Research   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ESOPHAGUS CARCINOMA; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; PRIORITY JOURNAL; SILENT GENE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CHROMOSOME DELETION; ESOPHAGEAL NEOPLASMS; GENES, P53; GENES, RETINOBLASTOMA; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027156696     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. DeCaprio, J. A., Ludlow, J. W., Frigge, J., Shew, J-Y., Huang, C-M., Lee, W-H., Marsillo, E., Paucha, E., and Livingstone, D. M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell, 54: 275-283, 1988.
2. Lane, D. P., and Crawford, L. V. T antigen is bound to a host protein in SV40-transformed cells. Nature (Lond.), 278: 261-263, 1979.
3. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
4. Lane, D. P., and Benchimol, S. p53: oncogene or anti-oncogene? Genes Dev., 4: 1-8, 1990.
5. Wolf, D., and Rotter, V. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc. Natl. Acad. Sci. USA, 82: 790-794, 1985.
6. Han, K-A., and Kulesz-Martin, M. F. Altered expression of wild-type p53 tumor suppressor gene during murine epithelial cell transformation. Cancer Res., 52: 749-753, 1992.
7. Harbour, J. W., Lai, S-L., Whang-Peng, J., Gazdar, A. F., Minna, J. D., and Kaye, F. J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (Washington DC), 241: 353-357, 1988.
8. Cheng, J., and Haas, M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol. Cell. Biol., 10: 5502-5509, 1990.
9. Chen, Y-C., Chen, P-J., Yeh, S-H., Tien, H-F., Wang, C-H., Tang, J-L., and Hong, R-L. Deletion of the human retinoblastoma gene in primary leukemias. Blood, 76: 2060-2064, 1991.
10. Strohmeyer, T., Reissmann, P., Cordon-Cardo, C., Hartmann, M., Ackermann, R., and Slamon, D. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc. Natl. Acad. Sci. USA, 88: 6662-6666, 1991.
11. Lee, E. Y.-H. P., To, H., Shew, J-Y., Bookstein, R., Scully, P., and Lee, W.-H. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science (Washington DC), 241: 218-221, 1988.
12. Ishikawa, J., Xu, H-J., Hu, S-X., Yandell, D. W., Maeda, S., Kamidono, S., Benedict, W. F., and Takahashi, R. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res., 51: 5736-5743, 1991.
13. Bookstein, R., Rio, P., Madreperla, S. A., Hong, F., Allred, C., Grizzle, W. E., and Lee, W-H. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc. Natl. Acad. Sci. USA, 87: 7762-7766, 1990.
14. Boring, C. C., Squires, T. S., and Tong, T. Cancer statistics, 1991. CA Cancer J. Clin., 41: 19-36, 1991.
15. Franceschi, S., Talamini, R., Barra, S., Baron, A. E., Negri, E., Bidoli, E., Serraino, D., and La Vecchia, C. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res., 50: 6502-6507, 1990.
16. Hamilton, S. R., Smith, R. L., and Cameron, J. L. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum. Pathol., 19: 942-948, 1988.
17. Meltzer, S. J., Mane, S. M., Wood, P. K., Resau, J. H., Newkirk, C., Terzakis, J. A., Korelitz, B. I., Weinstein, W. M., and Needleman, S. W. Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. Cancer Res., 50: 3627-3630, 1990.
18. Hollstein, M. C., Peri, L., Mandard, A. M., Welsh, J. A., Montesano, R., Metcalf, R. A., Bak, M., and Harris, C. C. Genetic analysis of human esophageal tumors from two high incidence geographical areas: frequent p53 base substitution and absence of ras mutations. Cancer Res., 51: 4102-4106, 1991.
19. Yamamoto, T., Kamata, N., Kawano, H., Shimizu, S., Kuroki, T., Toyoshima, K., Rikimaru, K., Nomura, N., Ishizaki, R., Pastan, I., Gamou, S., and Shimizu, N. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res., 46: 414-416, 1986.
20. Tsutsumi, M., Sakamoto, H., Yoshida, T., Kakizoe, T., Koiso, K., Sugimura, T., and Terada, M. Coamplifications of the hst-1 and int-2 genes in human cancers. Jpn. J. Cancer Res., 79: 428-432, 1988.
21. Lu, S-H., Hsieh, L-L., Luo, F-C., and Weinstein, I. B. Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int. J. Cancer, 42: 502-505, 1988.
22. Wagata, T., Ishizaki, K., Imamura, M., Shimada, Y., Ikenaga, M., and Tobe, T. Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. Cancer Res., 57: 2113-2117, 1991.
23. Meltzer, S. J., Yin, J., Huang, Y., McDaniel, T. K., Newkirk, C., Iseri, O., Vogelstein, B., and Resau, J. H. Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 88: 4976-4980, 1991.
24. Boynton, R. F., Huang, Y., Blount, P. L., Reid, B. J., Raskind, W. H., Haggitt, R. C., Newkirk, C., Resau, J. H., Yin, J., McDaniel, T., and Meltzer, S. J. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res., 51: 5766-5769, 1991.
25. Boynton, R. F., Blount, P. L., Yin, J., Brown, V. L., Huang, Y., Tong, Y., McDaniel, T., Newkirk, C., Resau, J. H., Raskind, W. H., Haggitt, R. C., Reid, B. J., and Meltzer, S. J. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc. Natl. Acad. Sci. USA, 89: 3385-3388, 1992.
26. Hollstein, M. C., Metcalf, R. A., Welsh, J. A., Montesano, R., and Harris, C. C. Frequent mutation of the p53 gene in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 87: 9958-9961, 1990.
27. Casson, A. G., Mukhopadhyay, T., Cleary, K. R., Ro, J. Y., Levin, B., and Roth, J. A. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res., 51: 4495-4499, 1991.
28. Greenwald, B. D., Huang, Y., Baum, R., and Meltzer, S. J. Barrett's carcinoma in a 25-year-old man with point mutation of the p53 tumor suppressor gene. Int. J. Oncol., 1: 271-275, 1992.
29. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the PCR. Genomics, 5: 874-879, 1989.
30. Yin, J., Huang, Y., and Meltzer, S. J. Sequencing products of the polymerase chain reaction directly, without purification: update. In: J. Ellingboe and U. B. Gyllensten (eds.), The PCR Technique: DNA Sequencing, pp. 49-50. Natick, MA: Eaton Publishing Co., 1992.